美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
65162-370-09	65162-370	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106	N/A	ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	8 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-370-09)
65162-370-03	65162-370	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106	N/A	ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	8 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-370-03)
65162-369-09	65162-369	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106	N/A	ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	4 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-369-09)
65162-369-03	65162-369	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106	N/A	ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	4 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-369-03)
42291-053-30	42291-053	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20231107	N/A	ANDA	ANDA205002	AvKARE	FESOTERODINE FUMARATE	4 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-053-30)
42291-054-30	42291-054	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate	Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20231107	N/A	ANDA	ANDA205002	AvKARE	FESOTERODINE FUMARATE	8 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-054-30)